TP53 mutation screening for patients at risk of myeloid malignancy.

被引：0
|
作者：
Mukherjee, Devdeep
Lawal, Rialnat A.
Fitzhugh, Courtney
Dillon, Laura Williams
Hourigan, Christopher S.
机构：
[1] Natl Heart Lung & Blood Inst, Natl Inst Hlth, Hematol Branch, Lab Myeloid Malignancies, Bethesda, MD USA
[2] Natl Heart Lung & Blood Inst, Natl Inst Hlth, Cellular & Mol Therapeut Branch, Bethesda, MD USA
[3] NHLBI, NIH, Bethesda, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6546
引用
收藏
页数：1
相关论文
共 50 条
  • [41] TP53 mutations and relevance of expression of TP53 pathway genes in paediatric acute myeloid leukaemia
    Cucchi, David G. J.
    Bachas, Costa
    Klein, Kim
    Huttenhuis, Sander
    Zwaan, Christian M.
    Ossenkoppele, Gert J.
    Janssen, Jeroen M. W. M.
    Kaspers, Gertjan L.
    Cloos, Jacqueline
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 188 (05) : 736 - 739
  • [42] INTRODUCING WILDTYPE TP53 IN TP53 MUTATED MYELOID LEUKEMIAS IMPROVES SENSITIVITY TO CHEMOTHERAPEUTIC DRUGS
    Maity, Arnab
    Illangeswaran, Raveen
    Rajamani, Bharathi
    Choudhury, Anurag
    Velayudhan, Shaji
    Kulkarni, Uday
    Balasubramanian, Poonkuzhali
    EXPERIMENTAL HEMATOLOGY, 2024, 137
  • [43] TP53 Allelic Status in TP53 Mutated Therapy-Related Myeloid Neoplasms is Inconsequential
    Zak, Taylor
    Sukhanova, Madina
    Gao, Juehua
    Behdad, Amir
    Chen, Yi-Hua
    Chen, Qing
    Tariq, Hamza
    LABORATORY INVESTIGATION, 2024, 104 (03) : S1520 - S1522
  • [44] Variation characteristics and clinical significance of TP53 in patients with myeloid neoplasms
    Ma, Qiang
    Liu, Yan
    Zhao, Hong
    Guo, Yixian
    Sun, Wanling
    Hu, Ronghua
    HEMATOLOGY, 2024, 29 (01)
  • [45] TP53 codon 72 polymorphism in patients with chronic myeloid leukemia
    Bergamaschi, G
    Merante, S
    Orlandi, E
    Galli, A
    Bernasconi, P
    Cazzola, M
    HAEMATOLOGICA, 2004, 89 (07) : 868 - 869
  • [46] THE PSYCHOSOCIAL EFFECTS OF A WHOLE BODY MRI SCREENING TRIAL IN SARCOMA PATIENTS WITH A GERMLINE TP53 MUTATION
    McBride, Kate A.
    Young, Mary-Anne
    Schlub, Timothy E.
    Kirk, Judy
    Tattersall, Martin H. N.
    Ballinger, Mandy
    Thomas, David
    Mitchell, Gillian
    Asia-Pacific Journal of Clinical Oncology, 2015, 11 : 178 - 178
  • [47] Mutation of the TP53 Gene in Placental Chorangiomatosis
    Luo, Ying
    FETAL AND PEDIATRIC PATHOLOGY, 2023, 42 (03) : 400 - 409
  • [48] Clinical significance of TP53 mutation in myeloma
    Chng, W. J.
    Price-Troska, T.
    Gonzalez-Paz, N.
    Van Wier, S.
    Jacobus, S.
    Blood, E.
    Henderson, K.
    Oken, M.
    Van Ness, B.
    Greipp, P.
    Rajkumar, S. V.
    Fonseca, R.
    LEUKEMIA, 2007, 21 (03) : 582 - 584
  • [49] TP53 mutation in mucinous carcinoma of the breast
    Di Palma, S
    Lavarino, C
    Oggionni, M
    Pilotti, S
    HISTOPATHOLOGY, 1999, 34 (06) : 559 - 560
  • [50] Sarcomas in TP53 germline mutation carriers
    Ognjanovic, Simona
    Olivier, Magali
    Bergemann, Tracy L.
    Hainaut, Pierre
    CANCER RESEARCH, 2011, 71
12345